These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23821269)

  • 1. Cell-based antiviral assays for screening and profiling inhibitors against dengue virus.
    Gong EY; Clynhens M; Ivens T; Lory P; Simmen K; Kraus G
    Methods Mol Biol; 2013; 1030():185-94. PubMed ID: 23821269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screening using dengue virus reporter genomes.
    Fischl W; Bartenschlager R
    Methods Mol Biol; 2013; 1030():205-19. PubMed ID: 23821271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
    Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
    J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and purification of dengue virus NS5 polymerase and development of a high-throughput enzymatic assay for screening inhibitors of dengue polymerase.
    Gong EY; Kenens H; Ivens T; Dockx K; Vermeiren K; Vandercruyssen G; Devogelaere B; Lory P; Kraus G
    Methods Mol Biol; 2013; 1030():237-47. PubMed ID: 23821273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a high-throughput antiviral assay for screening inhibitors of chikungunya virus and generation of drug-resistant mutations in cultured cells.
    Gong EY; Bonfanti JF; Ivens T; Van der Auwera M; Van Kerckhove B; Kraus G
    Methods Mol Biol; 2013; 1030():429-38. PubMed ID: 23821286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
    Zou G; Xu HY; Qing M; Wang QY; Shi PY
    Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.
    Talarico LB; Pujol CA; Zibetti RG; Faría PC; Noseda MD; Duarte ME; Damonte EB
    Antiviral Res; 2005 Jun; 66(2-3):103-10. PubMed ID: 15911027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
    Qing M; Liu W; Yuan Z; Gu F; Shi PY
    Antiviral Res; 2010 May; 86(2):163-71. PubMed ID: 20153777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
    Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
    Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
    Laosutthipong C; Kanthong N; Flegel TW
    Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
    Lee JC; Tseng CK; Wu YH; Kaushik-Basu N; Lin CK; Chen WC; Wu HN
    Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A duplex real-time RT-PCR assay for profiling inhibitors of four dengue serotypes.
    Gong EY; Smets A; Verheyen N; Clynhens M; Gustin E; Lory P; Kraus G
    Methods Mol Biol; 2013; 1030():195-203. PubMed ID: 23821270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for development of Dengue virus inhibitors.
    Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
    Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crotoxin and phospholipases A₂ from Crotalus durissus terrificus showed antiviral activity against dengue and yellow fever viruses.
    Muller VD; Russo RR; Cintra AC; Sartim MA; Alves-Paiva Rde M; Figueiredo LT; Sampaio SV; Aquino VH
    Toxicon; 2012 Mar; 59(4):507-15. PubMed ID: 21723310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-content assay to identify inhibitors of dengue virus infection.
    Shum D; Smith JL; Hirsch AJ; Bhinder B; Radu C; Stein DA; Nelson JA; Früh K; Djaballah H
    Assay Drug Dev Technol; 2010 Oct; 8(5):553-70. PubMed ID: 20973722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for screening and profiling inhibitors of herpes simplex viruses.
    Gong EY
    Methods Mol Biol; 2013; 1030():303-13. PubMed ID: 23821277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fluorescence-based high-throughput antiviral compound screening assay against respiratory syncytial virus.
    Kwanten L; De Clerck B; Roymans D
    Methods Mol Biol; 2013; 1030():337-44. PubMed ID: 23821280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule inhibitor discovery for dengue virus protease using high-throughput screening.
    Manzano M; Padia J; Padmanabhan R
    Methods Mol Biol; 2014; 1138():331-44. PubMed ID: 24696346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing antiviral compounds in a dengue mouse model.
    Schul W; Yip A; Shi PY
    Methods Mol Biol; 2013; 1030():269-81. PubMed ID: 23821275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.